| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |